Replimune Group (REPL) Financials

$9.51 -0.32 (-3.26%)

Closing price 06/17/2025 04:00 PM Eastern

Extended Trading

$9.75 +0.24 (+2.52%)

As of 06/17/2025 07:54 PM Eastern

Annual Income Statements for Replimune Group

This table shows Replimune Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2021	2022	2023	2024	2025
Period end date	3/31/2018	3/31/2019	3/31/2020	3/31/2021	3/31/2022	3/31/2023	3/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-20	-31	-53	-81	-118	-174	-216	-247
Consolidated Net Income / (Loss)	-20	-31	-56	-81	-118	-174	-216	-247
Net Income / (Loss) Continuing Operations	-20	-31	-56	-81	-118	-174	-216	-247
Total Pre-Tax Income	-20	-31	-56	-81	-118	-174	-215	-247
Total Operating Income	-19	-31	-56	-80	-118	-177	-235	-262
Total Gross Profit	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Cost of Revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Operating Expenses	19	31	56	80	118	177	233	262
Selling, General & Admin Expense	5.71	8.77	17	23	39	51	60	72
Research & Development Expense	14	22	39	57	80	127	173	189
Total Other Income / (Expense), net	-0.47	0.11	0.49	-0.92	0.28	3.08	17	15
Interest Expense	0.00	0.00	1.92	3.97	2.22	4.16	6.66	7.89
Interest & Investment Income	0.29	2.59	2.42	0.92	0.39	10	23	21
Other Income / (Expense), net	-0.76	-2.47	-0.02	2.14	2.11	-2.76	0.77	1.57
Income Tax Expense	-	-	-	-	0.00	0.29	0.41	0.47
Basic Earnings per Share	($3.96)	($1.33)	($1.54)	($1.75)	($2.26)	($2.99)	($3.24)	($3.07)
Weighted Average Basic Shares Outstanding	4.98M	23.20M	34.26M	46.25M	52.21M	58.21M	66.57M	80.56M
Diluted Earnings per Share	($3.96)	($1.33)	($1.54)	($1.75)	($2.26)	($2.99)	($3.24)	($3.07)
Weighted Average Diluted Shares Outstanding	4.98M	23.20M	34.26M	46.25M	52.21M	58.21M	66.57M	80.56M
Weighted Average Basic & Diluted Shares Outstanding	4.98M	23.20M	34.26M	46.25M	49.07M	57.78M	61.42M	77.09M

This table shows Replimune Group's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-43	-40	-49	-50	-60	-51	-55	-54	-53	-66	-74
Consolidated Net Income / (Loss)	-43	-40	-49	-50	-60	-51	-55	-54	-53	-66	-74
Net Income / (Loss) Continuing Operations	-43	-40	-49	-50	-60	-51	-55	-54	-53	-66	-74
Total Pre-Tax Income	-43	-40	-49	-49	-60	-51	-55	-54	-53	-66	-74
Total Operating Income	-42	-42	-53	-56	-64	-57	-59	-57	-59	-66	-79
Total Operating Expenses	42	42	53	56	64	57	59	57	59	66	79
Selling, General & Admin Expense	13	11	15	15	15	14	16	14	15	18	24
Research & Development Expense	29	30	38	40	49	43	43	43	43	48	55
Total Other Income / (Expense), net	-1.52	1.94	4.04	6.29	3.59	5.89	3.61	3.60	5.86	0.25	5.09
Interest Expense	0.55	1.49	1.57	1.66	1.50	1.55	1.95	1.96	1.97	1.98	1.99
Interest & Investment Income	1.11	2.68	5.88	6.19	6.05	5.69	5.44	4.71	5.39	5.14	5.88
Other Income / (Expense), net	-2.09	0.75	-0.26	1.77	-0.97	1.76	0.13	0.84	2.44	-2.91	1.20
Income Tax Expense	0.00	0.00	0.29	0.20	-0.20	0.47	-0.07	0.00	0.00	0.58	-0.11
Basic Earnings per Share	($0.79)	($0.69)	($0.73)	($0.75)	($0.90)	($0.77)	($0.82)	($0.78)	($0.68)	($0.79)	($0.82)
Weighted Average Basic Shares Outstanding	54.77M	57.86M	58.21M	66.37M	66.58M	66.65M	66.57M	69.19M	78.57M	83.50M	80.56M
Diluted Earnings per Share	($0.79)	($0.69)	($0.73)	($0.75)	($0.90)	($0.77)	($0.82)	($0.78)	($0.68)	($0.79)	($0.82)
Weighted Average Diluted Shares Outstanding	54.77M	57.86M	58.21M	66.37M	66.58M	66.65M	66.57M	69.19M	78.57M	83.50M	80.56M
Weighted Average Basic & Diluted Shares Outstanding	-	56.65M	57.78M	59.00M	59.06M	61.39M	61.42M	68.32M	68.42M	77.01M	77.09M

This table details how cash moves in and out of Replimune Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2021	2022	2023	2024	2025
Period end date	3/31/2018	3/31/2019	3/31/2020	3/31/2021	3/31/2022	3/31/2023	3/31/2024	3/31/2025
Net Change in Cash & Equivalents	-58	9.23	34	123	-77	41	-72	37
Net Cash From Operating Activities	-16	-25	-61	-61	-82	-128	-185	-192
Net Cash From Continuing Operating Activities	-16	-25	-61	-61	-82	-128	-185	-192
Net Income / (Loss) Continuing Operations	-20	-31	-53	-81	-118	-174	-216	-247
Consolidated Net Income / (Loss)	-20	-31	-53	-81	-118	-174	-216	-247
Depreciation Expense	0.11	0.15	0.53	1.71	2.15	2.45	2.66	3.50
Amortization Expense	-0.12	-1.72	-0.95	1.38	2.22	-5.64	-12	-8.95
Non-Cash Adjustments To Reconcile Net Income	1.04	8.02	-7.11	16	27	37	36	41
Changes in Operating Assets and Liabilities, net	2.66	-1.00	-0.41	0.34	4.96	13	4.36	20
Net Cash From Investing Activities	-44	-66	-5.23	-189	-1.81	-143	97	-24
Net Cash From Continuing Investing Activities	-44	-66	-5.23	-189	-1.81	-143	97	-24
Purchase of Property, Plant & Equipment	-0.14	-2.60	-6.54	-2.39	-2.34	-2.27	-5.66	-6.69
Purchase of Investments	-52	-190	-150	-392	-256	-583	-490	-404
Sale and/or Maturity of Investments	8.55	127	151	206	256	443	592	386
Net Cash From Financing Activities	55	101	100	372	6.60	311	16	252
Net Cash From Continuing Financing Activities	0.00	101	100	372	6.60	311	16	252
Issuance of Debt	0.00	0.00	10	-	0.00	28	15	0.00
Issuance of Common Equity	0.00	103	90	378	0.00	280	0.00	253
Other Financing Activities, net	0.00	0.21	0.49	5.60	6.60	3.08	1.28	-0.33
Effect of Exchange Rate Changes	2.30	-0.84	-	0.72	0.82	-0.11	-0.09	0.32
Cash Interest Paid	0.00	0.00	0.58	0.64	0.00	1.07	3.04	4.20
Cash Income Taxes Paid	-	-	-	0.00	0.06	0.00	0.30	0.11

This table details how cash moves in and out of Replimune Group's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Change in Cash & Equivalents	-23	118	-60	-40	-30	22	-23	77	-38	59	-61
Net Cash From Operating Activities	-33	-29	-33	-49	-44	-47	-46	-49	-39	-51	-54
Net Cash From Continuing Operating Activities	-33	-29	-33	-49	-44	-47	-46	-49	-39	-51	-54
Net Income / (Loss) Continuing Operations	-43	-40	-49	-50	-60	-51	-55	-54	-53	-66	-74
Consolidated Net Income / (Loss)	-43	-40	-49	-50	-60	-51	-55	-54	-53	-66	-74
Depreciation Expense	0.62	0.68	0.53	0.62	0.65	0.68	0.71	0.74	0.93	0.99	0.85
Amortization Expense	-0.40	-1.62	-3.86	-4.09	-2.37	-3.06	-2.81	-2.79	-2.43	-1.79	-1.94
Non-Cash Adjustments To Reconcile Net Income	7.16	10	12	8.09	11	7.50	8.95	9.79	10	13	7.87
Changes in Operating Assets and Liabilities, net	2.52	1.82	7.34	-3.65	7.07	-1.12	2.06	-3.13	5.47	3.71	14
Net Cash From Investing Activities	0.04	-125	-23	7.36	13	54	23	30	0.46	-46	-7.70
Net Cash From Continuing Investing Activities	0.04	-125	-23	7.36	13	54	23	30	0.46	-46	-7.70
Purchase of Property, Plant & Equipment	-0.40	-0.56	-0.25	-0.45	-1.75	-1.72	-1.74	-1.67	-2.08	-1.80	-1.13
Purchase of Investments	-133	-240	-150	-169	-112	-100	-108	-105	-89	-137	-72
Sale and/or Maturity of Investments	134	116	127	177	126	156	133	137	92	93	65
Net Cash From Financing Activities	7.42	271	-0.08	1.11	0.44	15	-0.13	97	-0.04	156	-0.13
Net Cash From Continuing Financing Activities	7.42	271	-0.08	1.11	0.44	15	-0.13	97	-0.04	156	-0.13
Issuance of Common Equity	6.40	243	-0.25	0.00	-	-	-	97	-	156	-0.00
Other Financing Activities, net	1.02	0.40	0.17	1.11	0.44	-0.13	-0.13	-0.07	-0.04	-0.10	-0.13
Effect of Exchange Rate Changes	2.44	-0.01	-4.45	0.01	-0.02	-0.03	-0.06	-0.04	0.06	-0.15	0.44
Cash Interest Paid	-	-	1.07	0.65	0.69	0.69	1.01	1.05	1.81	0.29	1.04

This table presents Replimune Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2021	2022	2023	2024	2025
Period end date	3/31/2018	3/31/2019	3/31/2020	3/31/2021	3/31/2022	3/31/2023	3/31/2024	3/31/2025
Total Assets	65	154	234	543	461	647	488	551
Total Current Assets	65	141	174	484	404	593	434	496
Cash & Equivalents	18	26	60	183	106	147	74	111
Short-Term Investments	44	109	109	294	290	437	346	373
Prepaid Expenses	0.76	3.70	2.73	4.49	5.27	6.28	8.08	8.35
Other Current Assets	2.39	2.47	2.96	2.95	3.06	2.94	4.92	3.73
Plant, Property, & Equipment, net	0.37	12	6.86	7.44	7.93	7.48	10	14
Total Noncurrent Assets	0.08	1.19	53	52	49	47	44	42
Noncurrent Note & Lease Receivables	-	0.00	51	45	42	40	37	35
Other Noncurrent Operating Assets	0.08	1.19	1.64	7.39	7.19	6.84	6.34	6.90
Total Liabilities & Shareholders' Equity	65	154	234	543	461	647	488	551
Total Liabilities	6.86	16	50	44	50	91	113	135
Total Current Liabilities	5.16	9.89	12	15	21	34	40	62
Accounts Payable	1.99	7.08	3.43	2.36	3.73	5.36	2.58	12
Accrued Expenses	3.17	2.80	5.16	8.74	13	25	34	46
Other Current Liabilities	-	0.00	3.28	3.46	3.63	3.76	3.88	3.98
Total Noncurrent Liabilities	1.69	6.59	39	30	29	57	73	73
Long-Term Debt	-	0.00	9.80	-	-	29	45	46
Capital Lease Obligations	-	-	25	25	-	24	23	23
Other Noncurrent Operating Liabilities	1.64	6.56	3.74	5.08	29	4.86	4.56	4.02
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-28	138	184	499	411	555	375	416
Total Preferred & Common Equity	-28	138	184	499	411	555	375	416
Total Common Equity	-28	138	184	499	411	555	375	416
Common Stock	1.10	199	297	692	723	1,035	1,071	1,359
Retained Earnings	-29	-60	-112	-193	-311	-485	-701	-949
Accumulated Other Comprehensive Income / (Loss)	-0.24	-1.06	-0.98	-0.39	-0.97	5.73	4.86	5.45

This table presents Replimune Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	6/30/2022	12/31/2022	6/30/2023	9/30/2023	12/31/2023	6/30/2024	9/30/2024	12/31/2024
Total Assets	459	679	604	562	533	535	498	604
Total Current Assets	402	624	550	508	479	480	443	548
Cash & Equivalents	112	207	106	76	98	152	113	172
Short-Term Investments	283	410	433	421	369	317	319	364
Prepaid Expenses	4.04	5.59	7.90	8.51	8.52	6.26	8.53	7.97
Other Current Assets	2.83	2.00	3.05	2.90	4.30	4.93	2.05	3.07
Plant, Property, & Equipment, net	8.27	7.68	7.62	8.45	9.47	11	13	14
Total Noncurrent Assets	49	47	46	46	44	43	43	42
Noncurrent Note & Lease Receivables	41	40	39	38	38	37	36	35
Other Noncurrent Operating Assets	7.73	6.64	7.18	7.33	6.45	6.61	6.95	7.02
Total Liabilities & Shareholders' Equity	459	679	604	562	533	535	498	604
Total Liabilities	49	83	90	97	111	109	117	121
Total Current Liabilities	20	26	32	40	39	36	44	48
Accounts Payable	4.48	3.65	4.88	4.37	3.90	0.86	8.41	7.19
Accrued Expenses	12	19	24	32	31	31	31	37
Other Current Liabilities	3.62	3.66	3.80	3.82	3.86	3.90	3.96	3.94
Total Noncurrent Liabilities	29	57	58	57	73	73	73	73
Long-Term Debt	-	28	29	29	44	45	46	46
Capital Lease Obligations	24	24	24	24	24	23	23	23
Other Noncurrent Operating Liabilities	4.54	4.27	4.87	4.52	4.75	4.39	4.29	4.49
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	410	595	514	465	422	426	381	482
Total Preferred & Common Equity	410	595	514	465	422	426	381	482
Total Common Equity	410	595	514	465	422	426	381	482
Common Stock	763	1,028	1,045	1,055	1,063	1,177	1,186	1,351
Retained Earnings	-353	-436	-535	-595	-646	-755	-808	-874
Accumulated Other Comprehensive Income / (Loss)	0.52	3.74	3.97	5.49	4.73	4.32	3.63	6.16

This table displays calculated financial ratios and metrics derived from Replimune Group's official financial filings.

Metric	2017	2018	2019	2021	2022	2023	2024	2025
Period end date	3/31/2018	3/31/2019	3/31/2020	3/31/2021	3/31/2022	3/31/2023	3/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Growth	0.00%	25.11%	-61.85%	0.00%	-49.66%	-63.66%	-32.08%	-8.96%
EBIT Growth	0.00%	79.44%	-68.21%	0.00%	-49.34%	-54.77%	-29.05%	-11.13%
NOPAT Growth	0.00%	0.00%	0.00%	0.00%	-47.98%	-49.67%	-32.58%	-11.44%
Net Income Growth	0.00%	-113.00%	-80.67%	0.00%	-45.96%	-47.65%	-23.82%	-14.60%
EPS Growth	0.00%	132.83%	-15.79%	0.00%	-29.14%	-32.30%	-8.36%	5.25%
Operating Cash Flow Growth	0.00%	41.53%	-138.60%	0.00%	-33.87%	-55.82%	-44.84%	-3.66%
Free Cash Flow Firm Growth	0.00%	0.00%	0.00%	0.00%	0.00%	-159.46%	-21.81%	-0.21%
Invested Capital Growth	0.00%	293.46%	719.89%	0.00%	-66.98%	57.44%	-10.03%	-94.81%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	-40.83%	0.00%	0.00%	-2,630.80%	-16,530.25%	-1.74%	-7.49%
EBIT Q/Q Growth	0.00%	-70.07%	0.00%	0.00%	0.00%	0.00%	-2.37%	-8.11%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-2.51%	-8.53%
Net Income Q/Q Growth	0.00%	-60.85%	0.00%	0.00%	0.00%	0.00%	-2.78%	-8.35%
EPS Q/Q Growth	0.00%	64.25%	0.00%	0.00%	0.00%	0.00%	-2.86%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	-499.53%	0.00%	0.00%	-8.49%	-8.69%	-7.77%	-4.10%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	-5,892.45%	0.00%	0.00%	-841.89%	-6.47%	-1.22%
Invested Capital Q/Q Growth	0.00%	324.09%	0.00%	0.00%	-10.17%	-22.03%	-4.84%	-92.22%
Profitability Metrics	-	-	-	-	-	-	-	-
Gross Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profit (Net Income) Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Tax Burden Percent	200.00%	200.00%	100.00%	100.00%	100.00%	100.17%	100.19%	100.19%
Interest Burden Percent	198.24%	0.00%	99.10%	103.93%	101.58%	96.75%	92.81%	94.91%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-67.60%	-31.44%	-34.65%	-16.22%	-25.94%	-36.06%	-46.42%	-62.58%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	-296.96%	0.00%	-163.27%	-662.96%	-695.10%	-1,398.25%
Operating Return on Assets (OROA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (ROA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Common Equity (ROCE)	32.55%	-35.19%	-34.65%	-16.22%	-25.94%	-36.06%	-46.42%	-62.58%
Return on Equity Simple (ROE_SIMPLE)	70.19%	-22.37%	-30.32%	-16.22%	-28.70%	-31.39%	-57.62%	-59.47%
Net Operating Profit after Tax (NOPAT)	-27	0.00	-39	-56	-83	-124	-164	-183
NOPAT Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Nonoperating Expense Percent (NNEP)	-10.91%	-9.23%	-12.19%	-5.51%	-8.31%	-10.87%	-11.65%	-16.73%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-37.76%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings before Interest and Taxes (EBIT)	-28	-33	-56	-78	-116	-180	-232	-260
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-40	-35	-57	-75	-112	-183	-242	-266
Valuation Ratios	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	3.49	1.99	2.84	1.95	1.80	1.34	1.81
Price to Tangible Book Value (P/TBV)	0.00	6.06	1.99	2.84	1.95	1.80	1.34	1.81
Price to Revenue (P/Rev)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	185.59	4.64	20.50	26.07	19.16	6.76	293.62
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.19	0.05	0.00	0.09	0.18	0.17
Long-Term Debt to Equity	0.00	0.00	0.19	0.05	0.00	0.09	0.18	0.17
Financial Leverage	-2.11	-1.00	-0.84	-0.91	-0.93	-0.96	-0.95	-0.97
Leverage Ratio	2.24	0.00	1.21	1.09	1.10	1.15	1.22	1.31
Compound Leverage Factor	2.20	2.06	1.20	1.13	1.12	1.11	1.13	1.25
Debt to Total Capital	0.00%	0.00%	15.91%	4.73%	0.00%	8.65%	15.41%	14.25%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	15.91%	4.73%	0.00%	8.65%	15.41%	14.25%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	148.15%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-48.15%	0.00%	84.09%	95.27%	100.00%	91.35%	84.59%	85.75%
Debt to EBITDA	0.00	0.00	-0.61	-0.33	0.00	-0.29	-0.28	-0.26
Net Debt to EBITDA	0.00	0.00	2.36	6.04	0.00	2.90	1.46	1.56
Long-Term Debt to EBITDA	0.00	0.00	-0.61	-0.33	0.00	-0.29	-0.28	-0.26
Debt to NOPAT	0.00	0.00	-0.88	-0.44	0.00	-0.42	-0.42	-0.38
Net Debt to NOPAT	0.00	0.00	3.40	8.07	0.00	4.28	2.14	2.26
Long-Term Debt to NOPAT	0.00	0.00	-0.88	-0.44	0.00	-0.42	-0.42	-0.38
Altman Z-Score	8.26	29.93	3.72	19.25	8.85	5.64	0.04	0.30
Noncontrolling Interest Sharing Ratio	296.30%	44.03%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-
Current Ratio	12.53	0.00	14.68	33.25	19.46	17.52	10.72	7.95
Quick Ratio	11.92	27.28	14.20	32.74	19.06	17.25	10.40	7.76
Cash Flow Metrics	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	0.00	-83	0.00	-51	-133	-162	-162
Operating Cash Flow to CapEx	-14,748.53%	-976.08%	-925.87%	-2,566.43%	-3,517.98%	-5,640.97%	-3,275.64%	-2,874.98%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	-43.35	0.00	-23.04	-31.95	-24.31	-20.55
Operating Cash Flow to Interest Expense	0.00	0.00	-31.55	-15.45	-36.97	-30.78	-27.85	-24.36
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	-34.96	-16.05	-38.02	-31.33	-28.70	-25.20
Efficiency Ratios	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-
Invested Capital	-6.52	6.09	50	47	16	25	22	1.15
Invested Capital Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Increase / (Decrease) in Invested Capital	0.00	25	44	0.00	-32	8.95	-2.46	-21
Enterprise Value (EV)	125	347	232	967	406	470	149	336
Market Capitalization	101	482	365	1,419	802	1,001	502	751
Book Value per Share	($5.64)	$4.36	$5.01	$10.73	$8.71	$9.80	$6.10	$5.40
Tangible Book Value per Share	($11.28)	$4.36	$5.01	$10.73	$8.71	$9.80	$6.10	$5.40
Total Capital	117	276	218	523	411	608	443	485
Total Debt	0.00	0.00	35	25	0.00	53	68	69
Total Long-Term Debt	0.00	0.00	35	25	0.00	53	68	69
Net Debt	-62	-135	-134	-452	-396	-531	-352	-415
Capital Expenditures (CapEx)	0.27	5.20	6.54	2.39	2.34	2.27	5.66	6.69
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-2.01	-3.72	-6.18	-7.10	-12	-25	-27	-50
Debt-free Net Working Capital (DFNWC)	119	262	162	469	383	559	393	434
Net Working Capital (NWC)	60	262	162	469	383	559	393	434
Net Nonoperating Expense (NNE)	12	18	16	25	35	50	51	64
Net Nonoperating Obligations (NNO)	-62	-135	-134	-452	-396	-531	-352	-415
Total Depreciation and Amortization (D&A)	-0.03	-1.57	-0.41	3.09	4.37	-3.19	-9.67	-5.45
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Debt-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Working Capital to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.55)	($3.96)	($1.54)	($1.75)	($2.26)	($2.99)	($3.24)	($3.07)
Adjusted Weighted Average Basic Shares Outstanding	4.98M	23.20M	36.78M	46.61M	52.21M	58.21M	66.57M	80.56M
Adjusted Diluted Earnings per Share	($1.55)	($3.96)	($1.54)	($1.75)	($2.26)	($2.99)	($3.24)	($3.07)
Adjusted Weighted Average Diluted Shares Outstanding	4.98M	23.20M	36.78M	46.61M	52.21M	58.21M	66.57M	80.56M
Adjusted Basic & Diluted Earnings per Share	($1.55)	($3.96)	($1.54)	($1.75)	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	4.97M	4.98M	34.26M	46.25M	49.07M	57.78M	61.42M	77.09M
Normalized Net Operating Profit after Tax (NOPAT)	-13	-43	-39	-56	-83	-124	-164	-183
Normalized NOPAT Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Pre Tax Income Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Debt Service Ratios	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	-29.29	-19.59	-52.27	-43.23	-34.85	-32.95
NOPAT to Interest Expense	0.00	0.00	-20.50	-14.09	-37.26	-29.80	-24.68	-23.20
EBIT Less CapEx to Interest Expense	0.00	0.00	-32.70	-20.19	-53.32	-43.78	-35.70	-33.79
NOPAT Less CapEx to Interest Expense	0.00	0.00	-23.91	-14.69	-38.31	-30.34	-25.53	-24.05
Payout Ratios	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	-0.64%	-0.12%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Replimune Group's official financial filings.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Growth	-40.11%	-43.17%	-5,891.81%	-39.27%	-53.07%	-36.70%	-7.32%	-2.13%	12.82%	-21.98%	-26.45%
EBIT Growth	-47.50%	-39.96%	0.00%	-28.15%	-48.40%	-34.02%	-10.07%	-4.90%	12.84%	-25.82%	-29.05%
NOPAT Growth	-42.17%	-40.18%	0.00%	-36.14%	-53.52%	-35.82%	-10.87%	-3.09%	7.70%	-16.77%	-35.01%
Net Income Growth	0.00%	-33.75%	0.00%	-17.28%	-39.31%	-28.80%	-11.85%	-8.51%	11.64%	-29.77%	-34.60%
EPS Growth	0.00%	-21.05%	0.00%	3.85%	-13.92%	-11.59%	-12.33%	-4.00%	24.44%	-2.60%	0.00%
Operating Cash Flow Growth	-44.64%	0.00%	-45.39%	-45.23%	-31.26%	-64.83%	-40.77%	-1.19%	11.36%	-7.62%	-16.39%
Free Cash Flow Firm Growth	51.98%	-184.50%	-245.71%	42.76%	-783.71%	27.60%	16.02%	-40.96%	42.35%	-20.53%	10.49%
Invested Capital Growth	-100.00%	81.39%	57.44%	-29.92%	0.00%	-26.29%	-10.03%	-6.87%	-15.11%	-36.55%	-94.81%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	-5.51%	3.77%	-35.32%	-1.35%	-15.97%	14.06%	-6.24%	3.55%	1.01%	-20.25%	-13.62%
EBIT Q/Q Growth	-3.85%	6.39%	-30.29%	-1.17%	-20.26%	15.46%	-7.01%	3.58%	0.08%	-22.03%	-13.36%
NOPAT Q/Q Growth	-1.72%	-0.12%	-27.30%	-5.01%	-14.70%	11.42%	-3.92%	2.36%	-2.70%	-12.06%	-20.15%
Net Income Q/Q Growth	-2.01%	7.92%	-24.06%	-0.64%	-21.17%	14.86%	-7.74%	2.37%	1.33%	-25.04%	-11.74%
EPS Q/Q Growth	-1.28%	12.66%	-5.80%	-2.74%	-20.00%	14.44%	-6.49%	4.88%	12.82%	-16.18%	-3.80%
Operating Cash Flow Q/Q Growth	0.73%	13.91%	-14.72%	-48.15%	10.29%	-8.11%	2.03%	-6.50%	21.41%	-31.25%	-5.95%
Free Cash Flow Firm Q/Q Growth	84.26%	-479.44%	-6.45%	41.05%	-143.05%	52.53%	-23.49%	1.07%	0.60%	0.75%	8.29%
Invested Capital Q/Q Growth	-100.00%	0.00%	-22.03%	12.88%	-23.11%	8.93%	-4.84%	16.85%	-29.91%	-18.58%	-92.22%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profit (Net Income) Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Tax Burden Percent	100.00%	100.00%	100.59%	100.41%	99.67%	100.93%	99.88%	100.00%	100.00%	100.87%	99.86%
Interest Burden Percent	98.71%	97.10%	91.91%	91.60%	92.98%	92.45%	94.06%	95.13%	93.94%	95.42%	95.02%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	0.00%	0.00%	-36.06%	-39.29%	-85.36%	-41.29%	-46.42%	-46.79%	-50.32%	-50.50%	-62.58%
Cash Return on Invested Capital (CROIC)	200.00%	-57.85%	-662.96%	-364.72%	-1,608.51%	-556.65%	-695.10%	-612.31%	-807.64%	-845.98%	-1,398.25%
Operating Return on Assets (OROA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (ROA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Common Equity (ROCE)	0.00%	0.00%	-36.06%	-39.29%	-85.36%	-41.29%	-46.42%	-46.79%	-50.32%	-50.50%	-62.58%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	0.00%	-35.33%	-42.68%	-49.81%	0.00%	-51.59%	-55.84%	-47.32%	0.00%
Net Operating Profit after Tax (NOPAT)	-29	-29	-37	-39	-45	-40	-41	-40	-41	-46	-56
NOPAT Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Nonoperating Expense Percent (NNEP)	-6.42%	-2.14%	-2.62%	-2.47%	-6.92%	-2.40%	-3.16%	-3.07%	-2.93%	-4.65%	-4.85%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-8.08%	-	-	-	-8.38%	-11.45%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings before Interest and Taxes (EBIT)	-44	-41	-53	-54	-65	-55	-59	-57	-56	-69	-78
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-43	-42	-57	-57	-67	-57	-61	-59	-58	-70	-79
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	2.25	1.80	2.61	2.17	1.18	1.34	1.30	1.96	1.72	1.81
Price to Tangible Book Value (P/TBV)	0.00	2.25	1.80	2.61	2.17	1.18	1.34	1.30	1.96	1.72	1.81
Price to Revenue (P/Rev)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	24.72	19.16	30.90	26.57	4.29	6.76	5.90	21.33	24.54	293.62
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	697.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	39.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.09	0.09	0.10	0.11	0.16	0.18	0.16	0.18	0.14	0.17
Long-Term Debt to Equity	0.00	0.09	0.09	0.10	0.11	0.16	0.18	0.16	0.18	0.14	0.17
Financial Leverage	-0.95	-0.95	-0.96	-0.93	-0.95	-0.95	-0.95	-0.94	-0.95	-0.96	-0.97
Leverage Ratio	1.10	1.13	1.15	1.15	1.21	1.19	1.22	1.21	1.25	1.26	1.31
Compound Leverage Factor	1.09	1.09	1.05	1.05	1.12	1.10	1.15	1.15	1.18	1.20	1.25
Debt to Total Capital	0.00%	8.10%	8.65%	9.31%	10.21%	13.89%	15.41%	13.83%	15.25%	12.49%	14.25%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	8.10%	8.65%	9.31%	10.21%	13.89%	15.41%	13.83%	15.25%	12.49%	14.25%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	91.90%	91.35%	90.69%	89.79%	86.11%	84.59%	86.17%	84.75%	87.51%	85.75%
Debt to EBITDA	0.00	47.11	-0.29	-0.26	-0.24	-0.29	-0.28	-0.28	-0.29	-0.28	-0.26
Net Debt to EBITDA	0.00	-506.19	2.90	2.44	2.00	1.68	1.46	1.65	1.55	1.89	1.56
Long-Term Debt to EBITDA	0.00	47.11	-0.29	-0.26	-0.24	-0.29	-0.28	-0.28	-0.29	-0.28	-0.26
Debt to NOPAT	0.00	0.00	-0.42	-0.39	-0.35	-0.42	-0.42	-0.41	-0.42	-0.41	-0.38
Net Debt to NOPAT	0.00	0.00	4.28	3.62	2.96	2.48	2.14	2.42	2.24	2.77	2.26
Long-Term Debt to NOPAT	0.00	0.00	-0.42	-0.39	-0.35	-0.42	-0.42	-0.41	-0.42	-0.41	-0.38
Altman Z-Score	0.00	9.63	6.29	8.45	5.37	1.64	1.22	1.73	2.16	2.69	1.39
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	23.58	17.52	17.06	12.76	12.40	10.72	13.46	10.11	11.43	7.95
Quick Ratio	0.00	23.29	17.25	16.72	12.47	12.07	10.40	13.15	9.87	11.20	7.76
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-7.46	-43	-46	-27	-66	-31	-39	-38	-38	-38	-35
Operating Cash Flow to CapEx	-8,386.36%	-5,151.17%	-13,066.14%	-10,821.38%	-2,485.18%	-2,741.30%	-2,653.22%	-2,945.90%	-1,854.08%	-2,817.39%	-4,738.18%
Free Cash Flow to Firm to Interest Expense	-13.57	-29.05	-29.34	-16.36	-44.06	-20.18	-19.81	-19.52	-19.31	-19.08	-17.43
Operating Cash Flow to Interest Expense	-60.38	-19.20	-20.90	-29.29	-29.12	-30.36	-23.65	-25.09	-19.62	-25.64	-27.05
Operating Cash Flow Less CapEx to Interest Expense	-61.10	-19.57	-21.06	-29.56	-30.29	-31.47	-24.54	-25.94	-20.68	-26.55	-27.63
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	31	25	28	21	23	22	26	18	15	1.15
Invested Capital Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Increase / (Decrease) in Invested Capital	-22	14	8.95	-12	21	-8.27	-2.46	-1.90	-3.22	-8.47	-21
Enterprise Value (EV)	852	777	470	855	566	100	149	152	385	361	336
Market Capitalization	852	1,341	1,001	1,342	1,009	498	502	553	749	829	751
Book Value per Share	$0.00	$10.29	$9.80	$8.90	$7.88	$7.14	$6.10	$6.94	$5.58	$7.05	$5.40
Tangible Book Value per Share	$0.00	$10.29	$9.80	$8.90	$7.88	$7.14	$6.10	$6.94	$5.58	$7.05	$5.40
Total Capital	0.00	648	608	567	518	490	443	495	450	551	485
Total Debt	0.00	52	53	53	53	68	68	68	69	69	69
Total Long-Term Debt	0.00	52	53	53	53	68	68	68	69	69	69
Net Debt	0.00	-564	-531	-486	-444	-398	-352	-401	-363	-468	-415
Capital Expenditures (CapEx)	0.40	0.56	0.25	0.45	1.75	1.72	1.74	1.67	2.08	1.80	1.13
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-19	-25	-21	-28	-26	-27	-24	-33	-37	-50
Debt-free Net Working Capital (DFNWC)	0.00	597	559	518	468	441	393	445	399	500	434
Net Working Capital (NWC)	0.00	597	559	518	468	441	393	445	399	500	434
Net Nonoperating Expense (NNE)	14	11	12	11	15	12	14	14	12	20	19
Net Nonoperating Obligations (NNO)	0.00	-564	-531	-486	-444	-398	-352	-401	-363	-468	-415
Total Depreciation and Amortization (D&A)	0.21	-0.94	-3.33	-3.47	-1.71	-2.38	-2.11	-2.05	-1.50	-0.80	-1.09
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Debt-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Working Capital to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($0.69)	($0.73)	($0.75)	($0.90)	($0.77)	($0.82)	($0.78)	($0.68)	($0.79)	($0.82)
Adjusted Weighted Average Basic Shares Outstanding	0.00	57.86M	58.21M	66.37M	66.58M	66.65M	66.57M	69.19M	78.57M	83.50M	80.56M
Adjusted Diluted Earnings per Share	$0.00	($0.69)	($0.73)	($0.75)	($0.90)	($0.77)	($0.82)	($0.78)	($0.68)	($0.79)	($0.82)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	57.86M	58.21M	66.37M	66.58M	66.65M	66.57M	69.19M	78.57M	83.50M	80.56M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	56.65M	57.78M	59.00M	59.06M	61.39M	61.42M	68.32M	68.42M	77.01M	77.09M
Normalized Net Operating Profit after Tax (NOPAT)	-29	-29	-37	-39	-45	-40	-41	-40	-41	-46	-56
Normalized NOPAT Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Pre Tax Income Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-79.39	-27.45	-33.94	-32.48	-43.28	-35.30	-30.03	-28.84	-28.68	-34.85	-39.34
NOPAT to Interest Expense	-52.92	-19.57	-23.64	-23.48	-29.85	-25.50	-21.07	-20.49	-20.95	-23.36	-27.96
EBIT Less CapEx to Interest Expense	-80.11	-27.82	-34.10	-32.75	-44.46	-36.40	-30.92	-29.69	-29.74	-35.76	-39.91
NOPAT Less CapEx to Interest Expense	-53.64	-19.94	-23.80	-23.75	-31.02	-26.61	-21.96	-21.34	-22.00	-24.27	-28.53
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Replimune Group's Financials

When does Replimune Group's financial year end?

According to the most recent income statement we have on file, Replimune Group's fiscal year ends in March. Their fiscal year 2025 ended on March 31, 2025.

How has Replimune Group's net income changed over the last 7 years?

Replimune Group's net income appears to be on an upward trend, with a most recent value of -$247.30 million in 2025, rising from -$19.70 million in 2017. The previous period was -$215.79 million in 2024. Find out what analysts predict for Replimune Group in the coming months.

What is Replimune Group's operating income?

Replimune Group's total operating income in 2025 was -$261.63 million, based on the following breakdown:

Total Gross Profit: $0.00
Total Operating Expenses: $261.63 million

How has Replimune Group's revenue changed over the last 7 years?

Over the last 7 years, Replimune Group's total revenue changed from $0.00 in 2017 to $0.00 in 2025, a change of 0.0%.

How much debt does Replimune Group have?

Replimune Group's total liabilities were at $135.49 million at the end of 2025, a 19.7% increase from 2024, and a 1,875.6% increase since 2017.

How much cash does Replimune Group have?

In the past 7 years, Replimune Group's cash and equivalents has ranged from $17.58 million in 2017 to $182.52 million in 2021, and is currently $111.12 million as of their latest financial filing in 2025.

How has Replimune Group's book value per share changed over the last 7 years?

Over the last 7 years, Replimune Group's book value per share changed from -5.64 in 2017 to 5.40 in 2025, a change of -195.8%.

Related Companies

This page (NASDAQ:REPL) was last updated on 6/18/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Replimune Group (REPL) Financials

Frequently Asked Questions About Replimune Group's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Replimune Group (REPL) Financials

Annual Income Statements for Replimune Group

Quarterly Income Statements for Replimune Group

Annual Cash Flow Statements for Replimune Group

Quarterly Cash Flow Statements for Replimune Group

Annual Balance Sheets for Replimune Group

Quarterly Balance Sheets for Replimune Group

Annual Metrics And Ratios for Replimune Group

Quarterly Metrics And Ratios for Replimune Group

Frequently Asked Questions About Replimune Group's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools